[瘤学:2025年有什么新鲜事]
Caroline Schilt1, Melissa Christofis1, Nabila Ferahta1
1Service d'oncologie médicale, Département d'oncologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Revue medicale suisse
|January 22, 2026
概括
本文重点介绍了与瑞士相关的关键瘤学进展,重点关注分子定义的子宫内膜癌,老年人群的瘤学,以及胰腺癌的早期检测和治疗.
科学领域:
- 在瘤学瘤学.
- 生物标志物 生物标志物
- 老年病的医生 老年病的医生
背景情况:
- 瑞士面临着人口老龄化,增加了对老年瘤专业护理的需求.
- 分子诊断的进步正在完善癌症亚型和治疗策略.
- 从历史上看,胰腺癌在早期检测和有效治疗方面存在挑战.
研究的目的:
- 审查与瑞士相关的重大瘤学突破.
- 讨论分子生物标志物对子宫内膜癌的影响.
- 突出瘤老年病和胰腺癌管理方面的进展.
主要方法:
- 对最近的瘤学进展的文献综述.
- 在子宫内膜癌中应用分子生物标志物的分析.
- 检查瘤老年病学和胰腺癌研究当前的趋势.
主要成果:
- 子宫内膜癌的分类由分子生物标志物增强.
- 瘤老年病学已成为老年癌症患者的关键领域.
- 新的早期检测方法和向疗法对胰腺癌显示出前途.
结论:
- 分子定义的子宫内膜癌提供了改善的治疗分层.
- 老年医疗评估是老年人群癌症护理的组成部分.
- 新兴的战略为对抗胰腺癌提供了新的希望.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


